Drugs / MP4OX
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01973504 | Dec 2013 → Dec 2015 | lactic acidosis | Sangart | Withdrawn | No outcome recorded |
| Phase 2 | NCT01262196 | May 2011 → Oct 2012 | lactic acidosis | Sangart | Completed | No outcome recorded |
| Phase 2 | NCT01004198 | Dec 2009 → Jun 2010 | lactic acidosis | Sangart | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MP4OX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01262196 ↗ |
| Modality | Protein / enzyme biologic | “MP4OX is a pegylated hemoglobin-based colloid” NCT01004198 ↗ |